Vialase
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
95 Enterprise Ste 100, Aliso Viejo, Cali...Phone Number
(949) 538-6623Website
www.vialase.comRevenue
$12.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Vialase
ViaLase, Inc. is a globally-minded, venture capital-backed, clinical-stage medical technology company located in Aliso Viejo, CA. ViaLase is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment that enhances glaucoma patient care. With a leadership team that has vast experience developing, designing, manufacturing, and commercializing the first femtosecond lasers for ophthalmic surgery for refractive and cataract patients, ViaLase is now bringing that expertise and innovation to glaucoma patients. ViaLase believes in collaborating closely with health care providers, payers, societies, and patients to inform our product development and commercial activities with the goal of bringing this revolutionary treatment to glaucoma patients across the globe.Explore more
Popular SearchesViaLase IncSIC Code 38,384NAICS Code 33,339Show moreVialase Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vialase your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Vialase recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Vialase
Check out if Vialase is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Vialase has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Vialase has new funding data
Product Launch: Get notified when Vialase launches new products
Click to see if Vialase had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Vialase, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Vialase
Find 3 more new buyers
Compare Similar Companies to Vialase
Compare insights from companies similar to Vialase, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vialase is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vialase is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vialase.
Vialase financials insights
Gather financial insights about Vialase, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series C
$40M
Vialase Tech Stack
A closer look at the technologies used by Vialase
Most Recent Scoops
Promotion
Executive Move
Executive Moves, Promotion
Promotion
Executive Move
Shawn O'Neil has been promoted from Chief Commercial Officer to the role of Chief Executive Officer.
Executive Moves, Promotion
Lateral Move
Executive Move
Executive Moves, Lateral Move
Funding
Funding
Executive Move
Board of Directors
Vialase News & Media
ViaLase and the John A. Moran Eye Center Announce Research Partnership to Accelerate Glaucoma Research and Innovation
ALISO VIEJO, Calif.--(BUSINESS WIRE)-- #MoranEyeCenter--ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced a research partnership with the John A. Moran Eye Center at the University of Utah (Moran Eye Center), home to the renowned Alan S. Crandall Center for Glaucoma Innovation (Crandall Center). The collaboration will explore aqueous outflow dynamics of ViaLase’s novel ViaLase laser procedViaLase to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS)
ESCRS presentations will feature clinical data on the ViaLase® Laser, which recently received CE Mark approval in the European Union ALISO VIEJO, Calif., Sept. 3, 2024 /PRNewswire/ -- ViaLase, Inc., a clinical stage medical technology company focused on fueling the practice of...ViaLase to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS)
ESCRS presentations will feature clinical data on the ViaLase® Laser, which recently received CE Mark approval in the European Union ALISO VIEJO, Calif., Sept. 3, 2024 /PRNewswire/ -- ViaLase, Inc., a clinical stage medical technology company focused on fueling the practice of...ViaLase Closes $40 million Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma
Series C financing supports the continued advancement of ViaLase's clinical, regulatory and commercial milestones ALISA VIEJO, Calif., April 1, 2024 /PRNewswire/ -- ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vialase
Sign Up For FreeTo access detailed company insights
ViaLase, Inc. is a globally-minded, venture capital-backed, clinical-stage medical technology company located in Aliso Viejo, CA. ViaLase is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment that enhances glaucoma patient care. With a leadership t... Read More
